MedTrace Logo

Feasibility of a Molecular Characterisation Approach to Treatment

NCT02112357 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2014-04-17

No results posted yet for this study

Summary

This study will assess the feasibility of sequencing locally advanced/metastatic gastrointestinal cancers in real-time to enable future treatment stratification by molecular characteristics. Targeted next generation sequencing of a panel of genes will be performed on tumour specimens and results will be discussed at a Sequencing Tumour Board to establish if a patient is potentially suitable for a targeted therapy.

Conditions

  • Advanced Gastrointestinal Cancers

Sponsors & Collaborators

  • Royal Marsden NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Dr. Naureen Starling, BSc, MBBS, MRCP · Royal Marsden NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-08-31

Countries

  • United Kingdom

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02112357 on ClinicalTrials.gov